Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

Dr. Jens M. Warnecke

Dr. Jens M. Warnecke

Scientific Communication Manager
EUROIMMUN AG
Germany

Biography

Dr Jens M Warnecke is a Senior scientist at EUROIMMUN AG, an international provider of medical laboratory products for the diagnosis of autoimmune diseases, infections and allergies, and for molecular analyses. He is responsible for planning, set-up and conduct of validation studies for newly developed products in the field of infectious diseases. As a Senior Scientist he is responsible for scientific publications in peer reviewed journals and scientific presentations in the field of infectious diseases.

Research Interest

Dr Warnecke received his degree in Biochemistry from the Free University of Berlin in 1993 with a Diploma thesis in experimental oncology. He continued his academic training by investigating the enzymatic mechanisms of catalytic RNA molecules in Berlin and Lübeck and finished his PhD thesis with distinction in 1998. He spent his postdoc time at the private University Witten/Herdecke, investigating RNA-Protein interactions. After a second postdoc with Altana Pharma he was appointed as lecturer for molecular tumour biology in the Master degree course Molecular Life Sciences at the Medical University of Lübeck. With his research group he entered the field of tumour diagnostics, exploring the possibilities and functions of extracellular nucleic acids in body fluids. In 2008 he left academia to work as responsible Project Manager in phase II clinical trials in the field of oncology until end of 2013 before joining EUROIMMUN AG. Jens Warnecke has profound experience as a peer reviewer of scientific journals and is author of many scientific publications. He has a strong background in reviewing and designing pivotal studies.